Porton Pharma Solutions is a global company with over 4,200 employees and R&D and GMP-compliant manufacturing facilities across the US, EU, and China. It provides customer-centric, innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (such as ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products, from pre-clinical to commercial stages.

Type of Drugs Manufactured:

Small Molecule;Biologics;Cell & Gene Therapy

CDMO Services:

Drug Substance Manufacturing (API);Drug Product/FDF;Research & Development;Regulatory Services;Analytical Development;Process & Forumulation Development

CDMO Therapeutic Area:

Cardiovascular;Central Nervous System;Immunology;Infectious Disease;Oncology

Number of Facilities:

18

High Potent Products capabilities:

OEB 4-5 Highly Potent APIs (HPAPIs)

Facilities Locations:

Europe;North America;China

Regulatory Approvals for facilities:

USA – FDA;Europe – EMA or constituent countries;China – NMPA;ISO 14001;WHO

Manufacturing Technologies:

Creams/Gels/Ointments;Lyophilized amps/vials;Oral Liquids;Pre-Filled Syringes (PFS);Soft Gels;Sterile Ampoules;Tablets/Capsules